Psychedelic Therapeutics & Drug Development Conference
May 19 – 20, 2025 // San Diego, CA
Join Worldwide Clinical Trials at the Psychedelic Therapeutics & Drug Development Conference.
18
days leftAbout event
This event brings together the world’s leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. If you are attending the Psychedelic Therapeutics & Drug Development Conference stop and say hello to our team.
Date
Monday to Tuesday
May 19-20, 2025
Venue
DoubleTree by Hilton
7450 Hazard Center Dr
San Diego, CA 92108
Christine Moore, PhD
Vice President, Neuroscience, Scientific Solutions
Christine K. Moore, PhD, Vice President, Neuroscience, Scientific Solutions provides strategic scientific guidance across multiple programs, driving neuroscience clinical research of the highest quality for the company. With over 25 years of drug development and commercialization experience, Dr. Moore’s experience extends from scientific to operational expertise across neuroscience indications. As one of the original team members at Worldwide Clinical Trials, she has held diverse roles within CROs as well as with large and small pharma. Her unique and broad industry experience allows for planning clinical trials that are both methodologically rigorous and feasible, and that will ultimately enable commercial product adoption by payers and health care providers after approval.
